855775 | 18:0 Lyso PC
1-stearoyl-2-hydroxy-sn-glycero-3-phosphocholine
Please Confirm Your Location
Effective March 1, 2018, Merck KGaA, Darmstadt, Germany* is the exclusive Distributor of Avanti Research. Research Products for all countries except the United States. For product pricing and order placement, please click on the appropriate Location Box below.
For customers located outside the United States, you will be redirected to www.sigmaaldrich.com/avanti prior to completing your purchase. Thank you for your continued business and support of Avanti Research!
*The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada
18:0 Lyso PC
1-stearoyl-2-hydroxy-sn-glycero-3-phosphocholine
CAS Registry Number is a Registered Trademark of the American Chemical Society
PC(18:0/0:0)
110687
Charron DM, Yousefalizadeh G, Buzzá HH, Rajora MA, Chen J, Stamplecoskie KG, Zheng G. Photophysics of J-Aggregating Porphyrin-Lipid Photosensitizers in Liposomes: Impact of Lipid Saturation. Langmuir. 2020 May 11. doi: 10.1021/acs.langmuir.0c00843. Epub ahead of print. PMID: 32338515.
PubMed ID: 32338515Park JM, Kim MJ, Noh JY, Yun TG, Kang MJ, Lee SG, Yoo BC, Pyun JC. Simultaneous Analysis of Multiple Cancer Biomarkers Using MALDI-TOF Mass Spectrometry Based on a Parylene-Matrix Chip. J Am Soc Mass Spectrom. 2020 Apr 1;31(4):917-926. doi: 10.1021/jasms.9b00102. Epub 2020 Mar 24. PMID: 32154716.
PubMed ID: 32154716Knuplez E, Curcic S, Theiler A, Bärnthaler T, Trakaki A, Trieb M, Holzer M, Heinemann A, Zimmermann R, Sturm EM, Marsche G. Lysophosphatidylcholines inhibit human eosinophil activation and suppress eosinophil migration in vivo. Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Jul;1865(7):158686. doi: 10.1016/j.bbalip.2020.158686. Epub 2020 Mar 11. PMID: 32171907.
PubMed ID: 32171907Siriwardane DA, Wang C, Jiang W, Mudalige T. Quantification of phospholipid degradation products in liposomal pharmaceutical formulations by ultra performance liquid chromatography-mass spectrometry (UPLC-MS). Int J Pharm. 2020 Jan 24;578:119077. doi: 10.1016/j.ijpharm.2020.119077. Epub ahead of print. PMID: 31988036.
PubMed ID: 31988036Kari OK , Ndika J , Parkkila P , Louna A , Lajunen T , Puustinen A , Viitala T , Alenius H , Urtti A . In situ analysis of liposome hard and soft protein corona structure and composition in a single label-free workflow. Nanoscale. 2020 Jan 23;12(3):1728-1741. doi: 10.1039/c9nr08186k. PMID: 31894806.
PubMed ID: 31894806Chagas-Lima AC, Pereira MG, Fampa P, Lima MS, Kluck GEG, Atella GC. Bioactive lipids regulate Trypanosoma cruzi development. Parasitol Res. 2019 Sep;118(9):2609-2619. doi: 10.1007/s00436-019-06331-9. Epub 2019 Jul 2.
PubMed ID: 31267245Cai H, Cao T, Li N, Fang P, Xu P, Wu X, Zhang B, Xiang D. Quantitative monitoring of a panel of stress-induced biomarkers in human plasma by liquid chromatography-tandem mass spectrometry: an application in a comparative study between depressive patients and healthy subjects. Anal Bioanal Chem. 2019 Jun 14. doi: 10.1007/s00216-019-01956-2. [Epub ahead of print]
PubMed ID: 31201457Daniel J. Stephenson, H. Patrick MacKnight, L. Alexis Hoeferlin, Margaret A. Park, Jeremy C. Allegood, Christopher L. Cardona, and Charles E. Chalfant. A rapid and adaptable lipidomics method for quantitative UPLC-mass spectrometric analysis of phosphatidylethanolamine and phosphatidylcholine in vitro, and in cells. Anal. Methods, 2019,11, 1765-1776. doi: 10.1039/C9AY00052F
Cho Y, Woo JH, Kwon OS, Yoon SS, Son J. Alterations in phospholipid profiles of erythrocytes deep-frozen without cryoprotectants. Drug Test Anal. 2019 Apr 5. doi: 10.1002/dta.2600. [Epub ahead of print]
PubMed ID: 30950199Lee CW, Lee D, Lee EM, Park SJ, Ji DY, Lee DY, Jung YC. Lipidomic profiles disturbed by the internet gaming disorder in young Korean males. J Chromatogr B Analyt Technol Biomed Life Sci. 2019 May 1;1114-1115:119-124. doi: 10.1016/j.jchromb.2019.03.027. Epub 2019 Mar 23.
PubMed ID: 30951964Sadeghi N, Kok RJ, Bos C, Zandvliet M, Geerts WJC, Storm G, Moonen CTW, Lammers T, Deckers R. Hyperthermia-triggered release of hypoxic cell radiosensitizers from temperature-sensitive liposomes improves radiotherapy efficacy in vitro. Nanotechnology. 2019 Mar 5;30(26):264001. doi: 10.1088/1361-6528/ab0ce6. [Epub ahead of print]
PubMed ID: 30836341Kontturi LS, van den Dikkenberg J, Urtti A, Hennink WE, Mastrobattista E. Light-Triggered Cellular Delivery of Oligonucleotides. Pharmaceutics. 2019 Feb 21;11(2). pii: E90. doi: 10.3390/pharmaceutics11020090.
PubMed ID: 30795565Quan H, Bae HB, Hur YH, Lee KH, Lee CH, Jang EA, Jeong S. Stearoyl lysophosphatidylcholine inhibits LPS-induced extracellular release of HMGB1 through the G2A/calcium/CaMKKβ/AMPK pathway. Eur J Pharmacol. 2019 Feb 21;852:125-133. doi: 10.1016/j.ejphar.2019.02.038. [Epub ahead of print]
PubMed ID: 30797785Qin Q, Wang B, Wang J, Chang M, Xia T, Shi X, Xu G. A comprehensive strategy for studying protein-metabolite interactions by metabolomics and native mass spectrometry. Talanta. 2019 Mar 1;194:63-72. doi: 10.1016/j.talanta.2018.10.010. Epub 2018 Oct 10.
PubMed ID: 30609583Zhang Q, Xu H, Liu R, Gao P, Yang X, Jin W, Zhang Y, Bi K, Li Q. A Novel Strategy for Targeted Lipidomics Based on LC-Tandem-MS Parameters Prediction, Quantification, and Multiple Statistical Data Mining: Evaluation of Lysophosphatidylcholines as Potential Cancer Biomarkers. Anal Chem. 2019 Mar 5;91(5):3389-3396. doi: 10.1021/acs.analchem.8b04715. Epub 2019 Feb 12.
PubMed ID: 30689358S. Katsuta, T. Okano, H. Suzuki. Reagent Handling and Delivery System Using Cell-Sized Liposomes. 2018 IEEE 13th Annual International Conference on Nano/Micro Engineered and Molecular Systems (NEMS). 2018 Dec 06. doi: 10.1109/NEMS.2018.8556884
Ditz T, Schnapka-Hille L, Noack N, Dorow J, Ceglarek U, Niederwieser D, Schiller J, Fuchs B, Cross M. Phospholipase A2 products predict the hematopoietic support capacity of horse serum. Differentiation. 2019 Jan - Feb;105:27-32. doi: 10.1016/j.diff.2018.12.002. Epub 2018 Dec 6.
PubMed ID: 30554008Stafford, R.E., Fanni, T., Dennis, E.A. (1989) Interfacial properties and critical micelle concentration of lysophospholipids. Biochemistry. 28(12):5113-20.
PubMed ID: 2669968- Certificate of Analysis (Lot No. 855775C-25MG-A-082 and 5781CJA082)
- Certificate of Analysis (Lot No. 855775C-500MG-A-082 and 5781CPA082)
- Certificate of Analysis (Lot No. 855775P-1G-A-081 and 5781PQA081)
- Certificate of Analysis (Lot No. 855775P-200MG-A-082 and 5781PNA082)
- Certificate of Analysis (Lot No. 855775P-25MG-A-082 and 5781PJA082)
- Certificate of Analysis (Lot No. 855775P-500MG-A-081 and 5781PPA081)
- Certificate of Analysis (Lot No. 855775P-1G-A-082 and 5781PQA082)
- Certificate of Analysis (Lot No. 855775P-1G-A-083 and 5781PQA083)
- Certificate of Analysis (Lot No. 855775P-200MG-B-082 and 5781PNB082)
- Certificate of Analysis (Lot No. 855775P-25MG-B-082 and 5781PJB082)
- Certificate of Analysis (Lot No. 855775C-25MG-A-083 and 5781CJA083)
- Certificate of Analysis (Lot No. 855775C-500MG-A-083 and 5781CPA083)
- Certificate of Analysis (Lot No. 855775P-1G-A-084 and 5781PQA084)
- Certificate of Analysis (Lot No. 855775C-500MG-A-084 and 5781CPA084)
- Certificate of Analysis (Lot No. 855775P-500MG-A-085 and 5781PPA085)
- Certificate of Analysis (Lot No. 855775P-200MG-B-084 and 5781PNB084)
- Certificate of Analysis (Lot No. 855775P-200MG-A-084 and 5781PNA084)
- Certificate of Analysis (Lot No. 855775P-500MG-B-085 and 5781PPB085)
- Certificate of Analysis (Lot No. 855775P-500MG-C-085 and 5781PPC085)
- Certificate of Analysis (Lot No. 855775P-200MG-A-085 and 5781PNA085)
- Certificate of Analysis (Lot No. 855775C-25MG-A-085 and 5781CJA085)
- Certificate of Analysis (Lot No. 855775P-200MG-A-086 and 5781PNA086)
- Certificate of Analysis (Lot No. 855775P-1G-A-086 and 5781PQA086)
- Certificate of Analysis (Lot No. 855775P-500MG-A-087 and 5781PPA087)
- Certificate of Analysis (Lot No. 855775P-25MG-A-087 and 5781PJA087)
- Certificate of Analysis (Lot No. 855775C-25MG-A-087 and 5781CJA087)
- Certificate of Analysis (Lot No. 855775P-1G-A-087 and 5781PQA087)
- Certificate of Analysis (Lot No. 855775P-500MG-B-087 and 5781PPB087)
- Certificate of Analysis (Lot No. 855775P-200MG-A-087 and 5781PNA087)
- Certificate of Analysis (Lot No. 855775P-25MG-B-087 and 5781PJB087)
- Certificate of Analysis (Lot No. 855775P-1G-B-087 and 5781PQB087)
- Certificate of Analysis (Lot No. 855775P-500MG-C-087 and 5781PPC087)
- Certificate of Analysis (Lot No. 855775P-200MG-B-087 and 5781PNB087)
- Certificate of Analysis (Lot No. 855775C-25MG-B-087 and 5781CJB087)
- Certificate of Analysis (Lot No. 855775C-25MG-C-087 and 5781CJC087)
- Certificate of Analysis (Lot No. 855775P-25MG-C-087 and 5781PJC087)
- Certificate of Analysis (Lot No. 855775P-1G-C-087 and 5781PQC087)
- Certificate of Analysis (Lot No. 855775 P-1G- A 089 and 5781PQA089)
- Certificate of Analysis (Lot No. 855775P-500MG-B-089 and 5781PPB089)
- Certificate of Analysis (Lot No. 855775P-500MG-A-089 and 5781PPA089)
- Certificate of Analysis (Lot No. 855775C-500MG-A-090 and 5781CPA090)
- Certificate of Analysis (Lot No. 855775P-200MG-A-090 and 5781PNA090)
- Certificate of Analysis (Lot No. 855775P-500MG-A-090 and 5781PPA090)
- Certificate of Analysis (Lot No. 855775C-25MG-B-090 and 5781CJB090)
- Certificate of Analysis (Lot No. 855775P-1G-D-090 and 5781PQD090)
- Certificate of Analysis (Lot No. 855775P-25MG-C-090 and 5781PJC090)
- Certificate of Analysis (Lot No. 855775P-200MG-C-090 and 5781PNC090)
- Certificate of Analysis (Lot No. 855775P-500MG-B-090 and 5781PPB090)
- Certificate of Analysis (Lot No. 855775C-25MG-A-090 and 5781CJA090)
- Certificate of Analysis (Lot No. 855775P-1G-B-090 and 5781PQB090)
- Certificate of Analysis (Lot No. 855775P-25MG-B-090 and 5781PJB090)
- Certificate of Analysis (Lot No. 855775P-1G-C-090 and 5781PQC090)
- Certificate of Analysis (Lot No. 855775P-200MG-B-090 and 5781PNB090)
- Certificate of Analysis (Lot No. 855775C-500MG-B-090 and 5781CPB090)
- Certificate of Analysis (Lot No. 855775P-25MG-D-090 and 5781PJD090)
- Certificate of Analysis (Lot No. 855775P-25MG-E-090 and 5781PJE090)
- Certificate of Analysis (Lot No. 855775P-500MG-C-090 and 5781PPC090)
- Certificate of Analysis (Lot No. 855775P-1G-E-090 and 5781PQE090)
- Certificate of Analysis (Lot No. 855775P-200MG-D-090 and 5781PND090)
- Certificate of Analysis (Lot No. 855775P-25MG-F-090 and 5781PJF090)
- Certificate of Analysis (Lot No. 855775P-1G-A-091 and 5781PQA091)
- Certificate of Analysis (Lot No. 855775C-25MG-C-090 and 5781CJC090)